https://www.healio.com/news/cardiology/20221005/in-hf-dapagliflozin-benefits-similar-in-patients-with-improved-vs-consistently-high-ef
0
0
10/5/22 at 2:59pm
Organization
Healio
Authors
NATIONAL HARBOR, Md. — In a DELIVER subgroup analysis, dapagliflozin conferred similar benefit in patients with HF with improved ejection fraction prior to trial enrollment compared with those with consistently high EF.“Heart failure with improved…
Create an account
or login to join the discussion